NCT06504927 Biomarker Discovery in Lung Cancer - Malaysia
| NCT ID | NCT06504927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Malaya |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-01-16 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-01-16 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
Eligibility Criteria
Inclusion Criteria: * Male or female subjects aged 30 and above. * No previous history of any cancers. * Able to provide X-ray and/or LDCT results. * Have either COPD or pulmonary nodules measuring less than 11mm, or deemed not for biopsy by attending physician * Willing to go back for a follow-up X-ray or LDCT scan in the next clinical follow up as per standard of care. * Willing to provide up to 30mL of blood in month-0 (first visit) and up to 21mL in the next standard of care follow up visit (second visit). Exclusion Criteria: * Subject has received chemotherapy or radiotherapy for cancer treatment, and any other cancer-related treatment. * Subject is pregnant or lactating (self-declaration). * Subject is unwilling or unable to provide signed informed consent
Contact & Investigator
Mau Ern Poh
PRINCIPAL INVESTIGATOR
University of Malaya
Frequently Asked Questions
Who can join the NCT06504927 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06504927 currently recruiting?
Yes, NCT06504927 is actively recruiting participants. Contact the research team at ernestpoh@gmail.com for enrollment information.
Where is the NCT06504927 trial being conducted?
This trial is being conducted at Kuala Lumpur, Malaysia.
Who is sponsoring the NCT06504927 clinical trial?
NCT06504927 is sponsored by University of Malaya. The principal investigator is Mau Ern Poh at University of Malaya. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.